Latest News

  • Alkermes to Host Conference Call to Discuss Second Quarter 2014 Financial Results Read More
  • Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 8700 for Treatment of Multiple Sclerosis Read More
  • Alkermes Announces Notices of Allowance for U.S. Patents for Four CNS Pipeline Candidates Read More

Investors

Learn More

Working at Alkermes

Join Our Team